Results 231 to 240 of about 74,894 (279)
Case series: a rare dominant form of β-thalassemia successfully treated by luspatercept. [PDF]
Allard PN, Kulozik AE, Kunz JB.
europepmc +1 more source
Clinical and disease characteristics from REVEAL at time of enrollment (baseline): Prospective observational study of patients with polycythemia vera in the United States [PDF]
Boccia, Ralph V +7 more
core +1 more source
When Blood Disorders Meet Cancer: Uncovering the Oncogenic Landscape of Sickle Cell Disease. [PDF]
Casadessus E +5 more
europepmc +1 more source
Mistaken Administration of Hydroxyurea Instead of Tacrolimus in a Pediatric Kidney Transplant Recipient: A Case Report. [PDF]
Lafond S +4 more
europepmc +1 more source
Association of depression and hydroxyurea use with neuropathic pain in hemoglobinopathies. [PDF]
Demiray DY, Oktay G.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Molecular Physics, 2021
The assessment of drug delivery performance of fabricated pristine XC3 monolayers (X = B, N) for the hydroxyurea anticancer drug was performed using periodic DFT calculations.
Rezvan Rahimi +2 more
semanticscholar +1 more source
The assessment of drug delivery performance of fabricated pristine XC3 monolayers (X = B, N) for the hydroxyurea anticancer drug was performed using periodic DFT calculations.
Rezvan Rahimi +2 more
semanticscholar +1 more source
Archives of Dermatology, 1970
In a double-blind study, nine of ten cases of severe psoriasis demonstrated clinical and histopathologic response to hydroxyurea. No toxic reactions were noted. The drug may be less toxic than methotrexate and is efficacious in the management of psoriasis.
Robert B. Livingston, Stephen K. Carter
openaire +2 more sources
In a double-blind study, nine of ten cases of severe psoriasis demonstrated clinical and histopathologic response to hydroxyurea. No toxic reactions were noted. The drug may be less toxic than methotrexate and is efficacious in the management of psoriasis.
Robert B. Livingston, Stephen K. Carter
openaire +2 more sources

